BURLINGTON, N.C., Dec. 23, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
Click here to read the full press release from the Labcorp newsroom.